Why Sanofi's dengue fever vaccine fell short of expectations

Dengvaxia's post-launch plight reflects the difficulties of launching a vaccine. Is this a harbinger for future vaccine-marketing efforts?

from Most popular articles from Medical Marketing and Media http://ift.tt/2wE8lSt